Neogenomics (NEO) Current Leases (2010 - 2026)

Neogenomics (NEO) has 17 years of Current Leases data on file, last reported at $3.7 million in Q2 2026.

• Quarterly Current Leases fell 8.14% year-over-year to $3.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.7 million (down 8.14% YoY) and the FY2025 annual result came in at $4.8 million, up 41.26% from the prior year.
• Current Leases declined to $3.7 million in Q2 2026, from $4.8 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $7.4 million in Q2 2023 to a low of $3.1 million in Q1 2025.
• A 5-year average of $5.0 million and a median of $4.8 million in 2025 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2024 — Current Leases slumped 51.4% — and 2026, when it surged 57.01%.
• Tracing NEO's Current Leases over 5 years: stood at $6.6 million in 2022, then retreated by 14.79% to $5.6 million in 2023, then tumbled by 39.73% to $3.4 million in 2024, then surged by 41.26% to $4.8 million in 2025, then fell by 22.07% to $3.7 million in 2026.
• The last three Current Leases figures came in at $3.7 million (Q2 2026), $4.8 million (Q1 2026), and $4.8 million (Q4 2025), per Business Quant data.